April 2020

We View “Value” a Little Differently

Can a strategy have a “high quality” and “value” security selection discipline at the same time? As a portfolio manager for the Boston Trust Walden Large Cap Value strategy, I hear this question frequently. After all, on a personal level, almost every one of us has a story of buying the cheaper version of two items only to regret not spending more when the product didn’t live up to expectations. The good news is that we can identify stocks that meet our criteria for both value and financial quality. How we do that highlights a difference in how we think about value in contrast to our benchmark, the Russell 1000® Value Index.

The first step to understanding this difference is to examine how the benchmark is defined. Most institutional investors evaluate large cap value strategies against the Russell 1000® Value Index. In order to achieve its value tilt relative to the broader Russell 1000®, the index systematically includes “companies with lower price-to-book ratios and lower expected growth values”.1

 

Russell 1000® Value Index: Quantitative Approach

  • Companies with lower price-to-book ratios
  • Companies with lower expected growth values

 

This association of value with a lower price-to-book ratio is common in the industry, and the ease of calculation makes it a good fit for a rules-based index. However, a price-to-book approach alone doesn’t indicate any preference for quality, as investors may receive a lot of book value (i.e. equity) per each dollar invested, but there is no information as to how effectively the companies use that equity capital to generate economic returns (i.e. return on equity, economic value added, etc.).

The index construction component of lower growth exists as a mechanism to distinguish the Russell 1000® Value Index from its Russell 1000® Growth counterpart. While value isn’t typically associated with the fastest growing companies, investors might be surprised by the extent to which value indices systematically score growth as a negative factor. If you believe, as we do, that the ability to grow is an indicator of a business’s quality, it becomes clear why value investing, at least as defined by the Russell benchmark, is commonly associated with a preference for investing in lower quality companies.

At Boston Trust Walden, we believe value and quality can not only coexist, but that they are symbiotic. Warren Buffett said the intrinsic value of a business “is the discounted value of the cash that can be taken out of a business during its remaining life.”2 In accordance with this definition, we seek to invest in stocks with attractive “value” relative to price. More specifically, we look for companies that generate substantial earnings and cash flow up front. Then, we assess the ability of those companies to sustainably grow the cash flows over time. Using this framework, our different view of value compared to the benchmark becomes clear.

 

Boston Trust Walden Large Cap Value: Fundamental Approach

  • Higher quality companies that can sustainably grow cash flows over time
  • Stocks with attractive valuations, identified through a comprehensive analysis of fundamentals relative to peers, history, and prospects

 

Doing this in practice is not easy, requiring in depth reviews and monitoring of each investment. It would be difficult for any benchmark, which must rely on a rigid construction methodology, to replicate such an approach.

In order to illustrate this, we profile a networking equipment and services company held in the Boston Trust Walden Large Cap Value strategy. This technology company does not meet the Russell 1000® Value Index criteria for growth and valuation, and is thus not included in the benchmark. This exclusion may be due to its price-to-book ratio of 4.7x vs. the Russell 1000® Value at 1.6x. However, note in the table below that it is discounted relative to the benchmark according to all the other valuation measurements.

 

Characteristics of a Portfolio Company Excluded from the Russell 1000® Value Index

Chart Sources: Boston Trust Walden, FactSet, MSCI, Russell.
Data as of 3/31/20. Historical metrics are based on 5 years of data. The Average Price/Earnings (GAAP) is the inverse of the 5-year weighted average earnings yield, based on end-of-period price and the most recent twelve months of available earnings data. Earnings are “as reported” by the company in adherence with GAAP and include any extraordinary items. Companies reporting negative earnings are included in the calculation. The weighted average is calculated using end-of-period weights. The security presented is shown only to illustrate the firm’s investment analytics and its process for evaluating an issuer in the course of implementing its investment strategy. The security should not be viewed as a recommendation of the firm, and it should not be assumed that an investment in the security was or would be profitable. Information is for illustrative purposes only and is subject to change at any time without notice.

Past performance does not guarantee future results. Information provided herein is not intended to be used as investment advice, an offer to purchase or sell the securities, or a solicitation or offer to sell investment advisory services. Boston Trust Walden Company, its staff, and affiliates (collectively “BTW”) do not provide tax, accounting, or legal advice. You should consult with your legal or tax advisor prior to taking any action relating to the information contained herein. Opinions expressed may be different from time to time than those presented by different authors or BTW. Data contained herein are derived from sources believed to be reliable at time of publication however, they may not be complete or accurate at all times and we undertake no, obligation to advise you of any changes or to provide an update.

Russell Investment Group is the source and owner of all trademarks, service marks, and copyrights related to the Russell Indexes. Russell® is a trademark of Russell Investment Group.